Reply

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Retina

• Publication date

  2024-09-18

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1097/IAE.0000000000004266PMID 39312884PMCID 11559959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside

  2024cited by this paper
• LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration

  2023cited by this paper
• Cost of Ranibizumab Port Delivery System vs Intravitreal Injections for Patients With Neovascular Age-Related Macular Degeneration.

  2022cited by this paper
• Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry

  2022cited by this paper
• Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.

  2020cited by this paper
• C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.

  2020cited by this paper
• A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION

  2019cited by this paper
• Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab.

  2019cited by this paper
• Photobiomodulation for non-exudative age-related macular degeneration.

  2018cited by this paper
• Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report

  2017cited by this paper
• Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

  2016cited by this paper
• Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration.

  2014cited by this paper
• Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.

  2010cited by this paper
• [Age-related macular degeneration].

  2006cited by this paper
• � Correspondence

  year unknowncited by this paper

• Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results

  2025cites this paper
• Fluorescence Lifetime Imaging Ophthalmoscopy, Vision, and Chorioretinal Asymmetries in Aging and Age-Related Macular Degeneration: ALSTAR2

  2025cites this paper
• Potential vision tester using Maxwellian view, small pupil, and different levels of wavefront correction with adaptive optics

  2025cites this paper
• Improvement in Central Serous Chorioretinopathy Following Multiwavelength Photobiomodulation Treatment – Case Report

  2024cites this paper
• Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy

  2024influential citation